A novel cholesterol metabolite, 5-cholesten, 3beta-25-diol, disulfate (25HCDS) for therapy of metabolic disorders, hyperlipidemia, diabetes, fatty liver diseases and atherosclerosis

摘要

5-cholesten, 3&bgr;, 25-diol, disulfate (25HCDS) has been found to be an authentic PPAR